# Plegridy Satisfaction Study in Participants

> **NCT02587065** · PHASE4 · COMPLETED · sponsor: **Biogen** · enrollment: 193 (actual)

## Conditions studied

- Relapsing-Remitting Multiple Sclerosis (RRMS)

## Interventions

- **DRUG:** peginterferon beta-1a

## Key facts

- **NCT ID:** NCT02587065
- **Lead sponsor:** Biogen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02-03
- **Primary completion:** 2017-10-02
- **Final completion:** 2017-12-21
- **Target enrollment:** 193 (ACTUAL)
- **Last updated:** 2023-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02587065

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02587065, "Plegridy Satisfaction Study in Participants". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02587065. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*